Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Ana Urzainqui"'
Autor:
Esther San Antonio, Javier Silván, Javier Sevilla-Montero, Elena González-Sánchez, Antonio Muñoz-Callejas, Inés Sánchez-Abad, Alejandra Ramos-Manzano, Cecilia Muñoz-Calleja, Isidoro González-Álvaro, Eva G. Tomero, Javier García-Pérez, Rosario García-Vicuña, Esther F. Vicente-Rabaneda, Santos Castañeda, Ana Urzainqui
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundEarly diagnosis and treatment of Systemic lupus erythematosus (SLE) and Systemic sclerosis (SSc) present significant challenges for clinicians. Although various studies have observed changes in serum levels of selectins between healthy dono
Externí odkaz:
https://doaj.org/article/5783aa89857f464c8a98c268bfa965dc
Autor:
Pedro Martínez-Fleta, Esther F. Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria Montes, Noelia García-Castañeda, Gina P. Mejía-Abril, Jesús A. García-Vadillo, Irene Llorente-Cubas, José R. Villagrasa, José M. Serra López-Matencio, Julio Ancochea, Ana Urzainqui, Laura Esparcia-Pinedo, Arantzazu Alfranca, Hortensia de la Fuente, Rosario García-Vicuña, Francisco Sánchez-Madrid, Isidoro González-Álvaro, Santos Castañeda
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract B and T cell responses were evaluated in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) after 1 or 2 weeks of methotrexate (MTX) withdrawal following each COVID-19 vaccine dose and compared with those who maintained MTX
Externí odkaz:
https://doaj.org/article/68cb81a827cf4cafad508bc550296c46
Autor:
Antonio Muñoz-Callejas, Elena González-Sánchez, Javier Silván, Esther San Antonio, Rafael González-Tajuelo, Alejandra Ramos-Manzano, Inés Sánchez-Abad, Isidoro González-Alvaro, Javier García-Pérez, Eva G. Tomero, Rosario García de Vicuña, Esther F. Vicente-Rabaneda, Santos Castañeda, Ana Urzainqui
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6144 (2023)
Systemic Lupus Erythematosus (SLE) is an autoimmune disease characterized by the generation of anti-DNA autoantibodies due to exposure of immune cells to excessive amounts of extracellular DNA. Lack of P-selectin in mice induces the development of a
Externí odkaz:
https://doaj.org/article/a12b7fb1f2ba45f3baf8063acf11a674
Autor:
Carlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, Raquel Juárez-Sánchez, Javier Loscertales, Tamara Mateu-Albero, Lorena Vega-Piris, Marina Espartero-Santos, Ana Marcos-Jimenez, Blanca Andrea Sánchez-López, Yaiza Pérez-García, Dennis Jungherz, Sebastian Oberbeck, Linus Wahnschaffe, Anna Kreutzman, Emma I. Andersson, Satu Mustjoki, Edgar Faber, Ana Urzainqui, Manuel Fresno, Kostantino Stamatakis, Arantzazu Alfranca, Fernando Terrón, Marco Herling, María Luisa Toribio, Cecilia Muñoz-Calleja
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-17 (2020)
Abstract T-cell prolymphocytic leukemia (T-PLL) is a poor prognostic disease with very limited options of efficient therapies. Most patients are refractory to chemotherapies and despite high response rates after alemtuzumab, virtually all patients re
Externí odkaz:
https://doaj.org/article/de532df98e854abe8a204e17060b7cf5
Autor:
Rafael González-Tajuelo, Elena González-Sánchez, Javier Silván, Antonio Muñoz-Callejas, Esther Vicente-Rabaneda, Javier García-Pérez, Santos Castañeda, Ana Urzainqui
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
PSGL-1 is expressed in all plasma cells, but only in a small percentage of circulating B cells. Patients with systemic sclerosis (SSc) show reduced expression of PSGL-1 in B cells and increased prevalence of pulmonary arterial hypertension. PSGL-1 de
Externí odkaz:
https://doaj.org/article/10dec0b69e4d49959501ce2fe763bc9f
Autor:
Sergio Esteban, Cristina Clemente, Agnieszka Koziol, Pilar Gonzalo, Cristina Rius, Fernando Martínez, Pablo M Linares, María Chaparro, Ana Urzainqui, Vicente Andrés, Motoharu Seiki, Javier P Gisbert, Alicia G Arroyo
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 2, Pp n/a-n/a (2020)
Abstract Pathological angiogenesis contributes to cancer progression and chronic inflammatory diseases. In inflammatory bowel disease, the microvasculature expands by intussusceptive angiogenesis (IA), a poorly characterized mechanism involving incre
Externí odkaz:
https://doaj.org/article/9afa1d17714c4eba8342c3b1e489a00e
Autor:
Elisa Ramos-Sevillano, Ana Urzainqui, Belén de Andrés, Rafael González-Tajuelo, Mirian Domenech, Fernando González-Camacho, Francisco Sánchez-Madrid, Jeremy S Brown, Ernesto García, Jose Yuste
Publikováno v:
PLoS Pathogens, Vol 12, Iss 3, p e1005500 (2016)
Bacterial uptake by phagocytic cells is a vital event in the clearance of invading pathogens such as Streptococcus pneumoniae. A major role of the P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes against invasive pneumococcal disease is descri
Externí odkaz:
https://doaj.org/article/e17c4aab58d440748c6b19695e18efa9
Autor:
Lizbeth Estrada-Capetillo, Berenice Hernández-Castro, Adriana Monsiváis-Urenda, Crisol Alvarez-Quiroga, Esther Layseca-Espinosa, Carlos Abud-Mendoza, Lourdes Baranda, Ana Urzainqui, Francisco Sánchez-Madrid, Roberto González-Amaro
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Dendritic cells (DCs) have a key role in the regulation of immune response. We herein explored, in patients with inflammatory diseases, the role of monocyte derived DC’s (mo-DCs) on the generation of Th17 and T regulatory (Treg) lymphocytes. Periph
Externí odkaz:
https://doaj.org/article/5623be07e3e34606b422a2651d6ef056
Autor:
Elena González‐Sánchez, Antonio Muñoz‐Callejas, Javier Gómez‐Román, Esther San Antonio, Alessandro Marengo, Nicolas Tsapis, Kamila Bohne‐Japiassu, Rafael González‐Tajuelo, Saray Pereda, Javier García‐Pérez, Lorenzo Cavagna, Miguel Ángel González‐Gay, Esther Francisca Vicente‐Rabaneda, Federica Meloni, Elias Fattal, Santos Castañeda, Ana Urzainqui
Publikováno v:
British Journal of Pharmacology. 179:4534-4548
Interstitial lung disease (ILD) is the main cause of mortality in systemic sclerosis (SSc), and current therapies available are of low efficacy or high toxicity. Thus, the identification of innovative less toxic and high efficacy therapeutic approach
Autor:
Antonio Muñoz-Callejas, Juan M. Serrador, Angel Cogolludo, Luis Jesús Jiménez-Borreguero, Daniel Morales-Cano, Bianca Barreira, María de la Fuente-Fernández, Santos Castañeda, Rafael González-Tajuelo, Javier Silván, Elena González-Sánchez, Esther F Vicente-Rabaneda, Ana Urzainqui, Susana Cadenas, Marina Espartero-Santos, Carlos Gamallo, Francisco Perez-Vizcaino
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Arthritis & Rheumatology (Hoboken, N.j.)
instname
Arthritis & Rheumatology (Hoboken, N.j.)
Objective: Pulmonary arterial hypertension (PAH), one of the major complications of systemic sclerosis (SSc), is a rare disease with unknown etiopathogenesis and noncurative treatments. As mice deficient in P-selectin glycoprotein ligand 1 (PSGL-1) d